{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ORMP/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:25:40.364Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10935,"canonical_name":"ORAMED PHARMACEUTICALS INC.","cik":"0001176309","uei":null,"lei":null,"duns":null,"ticker":"ORMP"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-10-02","url_slug":"/sec/cik-0001176309/4/0001213900-26-106530","accession_number":"0001213900-26-106530","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-10-02","url_slug":"/sec/cik-0001176309/4/0001213900-26-106531","accession_number":"0001213900-26-106531","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — ORAMED PHARMACEUTICALS INC. — 2026-10-01","url_slug":"/sec/cik-0001176309/144/0001976408-26-000876","accession_number":"0001976408-26-000876","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — ORAMED PHARMACEUTICALS INC. — 2026-10-01","url_slug":"/sec/cik-0001176309/144/0001976408-26-000877","accession_number":"0001976408-26-000877","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-09-25","url_slug":"/sec/cik-0001176309/4/0001213900-26-103535","accession_number":"0001213900-26-103535","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-09-25","url_slug":"/sec/cik-0001176309/4/0001213900-26-103536","accession_number":"0001213900-26-103536","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-09-25","url_slug":"/sec/cik-0001176309/4/0001213900-26-103538","accession_number":"0001213900-26-103538","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-09-25","url_slug":"/sec/cik-0001176309/4/0001213900-26-103540","accession_number":"0001213900-26-103540","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"8-K","title":"8-K — ORAMED PHARMACEUTICALS INC. — 2026-09-17","url_slug":"/sec/cik-0001176309/8-k/0001213900-26-100929","accession_number":"0001213900-26-100929","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ORAMED PHARMACEUTICALS INC. — 2026-08-14","url_slug":"/sec/cik-0001176309/schedule-13g-a/0001493152-26-038125","accession_number":"0001493152-26-038125","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ORAMED PHARMACEUTICALS INC. — 2026-08-10","url_slug":"/sec/cik-0001176309/10-q/0001213900-26-087361","accession_number":"0001213900-26-087361","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — ORAMED PHARMACEUTICALS INC. — 2026-08-03","url_slug":"/sec/cik-0001176309/def-14a/0001213900-26-084609","accession_number":"0001213900-26-084609","importance":40},{"ts":"2026-08-03","kind":"sec.filing","form_type":"ARS","title":"ARS — ORAMED PHARMACEUTICALS INC. — 2026-08-03","url_slug":"/sec/cik-0001176309/ars/0001213900-26-084613","accession_number":"0001213900-26-084613","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — ORAMED PHARMACEUTICALS INC. — 2026-08-03","url_slug":"/sec/cik-0001176309/defa14a/0001213900-26-084612","accession_number":"0001213900-26-084612","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — ORAMED PHARMACEUTICALS INC. — 2026-07-22","url_slug":"/sec/cik-0001176309/schedule-13d-a/0001213900-26-080406","accession_number":"0001213900-26-080406","importance":70},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-07-02","url_slug":"/sec/cik-0001176309/4/0001213900-26-075069","accession_number":"0001213900-26-075069","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ORAMED PHARMACEUTICALS INC. — 2026-07-02","url_slug":"/sec/cik-0001176309/4/0001213900-26-075070","accession_number":"0001213900-26-075070","importance":30},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"Hexter Joshua","title":"COO & CBO","shares":50000,"price_per_share":3.69,"usd_value":184500,"security_title":"Common Stock","importance":15.1845},{"ts":"2026-07-01","kind":"sec.form144","reporter":"Hexter Joshua","title":"Officer","shares":137000,"usd_value":658970,"security_title":"Common Stock","approx_sale_date":"2026-07-01","accession_number":"0001976408-26-000609","importance":40.131794},{"ts":"2026-07-01","kind":"sec.form144","reporter":"Gabay Avraham","title":"Officer","shares":93360,"usd_value":449062,"security_title":"Common Stock","approx_sale_date":"2026-07-01","accession_number":"0001976408-26-000608","importance":40.08981232},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Hexter Joshua","title":"COO & CBO","shares":137000,"price_per_share":4.463,"usd_value":611431,"security_title":"Common Stock","importance":35.611431},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Gabay Avraham","title":"Chief Financial Officer","shares":73360,"price_per_share":4.5085,"usd_value":330744,"security_title":"Common Stock","importance":35.33074356},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — ORAMED PHARMACEUTICALS INC. — 2026-06-30","url_slug":"/sec/cik-0001176309/8-k/0001213900-26-073709","accession_number":"0001213900-26-073709","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ORAMED PHARMACEUTICALS INC. — 2026-06-29","url_slug":"/sec/cik-0001176309/schedule-13g-a/0001373604-26-000047","accession_number":"0001373604-26-000047","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ORAMED PHARMACEUTICALS INC. — 2026-05-15","url_slug":"/sec/cik-0001176309/schedule-13g/0001493152-26-023496","accession_number":"0001493152-26-023496","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"NT 10-Q","title":"NT 10-Q — ORAMED PHARMACEUTICALS INC. — 2026-05-15","url_slug":"/sec/cik-0001176309/nt-10-q/0001213900-26-057722","accession_number":"0001213900-26-057722","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"SCHEDULE 13D","title":"SCHEDULE 13D — ORAMED PHARMACEUTICALS INC. — 2026-05-14","url_slug":"/sec/cik-0001176309/schedule-13d/0001213900-26-056837","accession_number":"0001213900-26-056837","importance":75},{"ts":"2026-05-14","kind":"sec.filing","form_type":"3","title":"3 — ORAMED PHARMACEUTICALS INC. — 2026-05-14","url_slug":"/sec/cik-0001176309/3/0001213900-26-056839","accession_number":"0001213900-26-056839","importance":30}]}